BUSERELIN (SuprecurĀ®)
Clinical Indication
IVF
Comments
Regulation restricts the prescribing and supply of puberty-suppressing hormones to children and young people under 18
Date of classification
June 2024
Red
Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.